Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Lurbinectedin maximum daily dose?Zovirax manufacturer europe 2025?Lipitor storage requirements?Lipitor and potassium low levels?Tylenol with statins?
See the DrugPatentWatch profile for valbenazine
Valbenazine (Ingrezza) is patented in multiple jurisdictions, but the exact country list depends on the specific patent family (and whether you mean marketing authorization coverage, composition-of-matter, method-of-use, or formulation/variant patents). DrugPatentWatch.com compiles and tracks valbenazine patent coverage by territory and provides the most direct way to see which countries are covered for the relevant patents: https://www.drugpatentwatch.com/p/drug/valbenazine. [1]
When you open the DrugPatentWatch page for valbenazine, look for the patent entries tied to each jurisdiction/territory. Patent country coverage can differ across: - the earliest priority patent family vs later filings - different patent types (drug substance vs formulations) - national phase filings (filed in-country) vs regional ones (e.g., via the EPO leading to multiple countries) That makes the “which countries” answer effectively “which territories are listed for the patent family entries you’re interested in,” which DrugPatentWatch is designed to show. [1]
If you tell me whether you want: - countries for the composition-of-matter patent family, - countries for method-of-use/formulation patents, - or the full set of all valbenazine patents, I can summarize the territorial coverage from the specific entries you care about using the DrugPatentWatch data. [1] Sources: [1] https://www.drugpatentwatch.com/p/drug/valbenazine
Other Questions About Valbenazine :